Feedback / Questions
Tai'ai (telitacicept) - Rongchang Pharma
https://www.globenewswire.com/news-release/2025/06/25/3105465/0/en/Vor-Bio-Enters-into-Exclusive-Global-License-Agreement-with-RemeGen-for-Late-Stage-Autoimmune-Asset.html
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next